Geode Capital Management LLC Decreases Stake in OmniAb, Inc. (NASDAQ:OABI)

Geode Capital Management LLC cut its position in OmniAb, Inc. (NASDAQ:OABI) by 0.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,325,381 shares of the company’s stock after selling 12,906 shares during the period. Geode Capital Management LLC’s holdings in OmniAb were worth $9,838,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. CWC Advisors LLC. acquired a new position in shares of OmniAb during the third quarter worth $54,000. Walleye Capital LLC purchased a new stake in OmniAb during the 3rd quarter worth about $61,000. Intech Investment Management LLC acquired a new position in shares of OmniAb during the 3rd quarter worth about $70,000. China Universal Asset Management Co. Ltd. increased its holdings in shares of OmniAb by 64.5% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 22,727 shares of the company’s stock valued at $96,000 after acquiring an additional 8,909 shares during the last quarter. Finally, Palumbo Wealth Management LLC raised its position in shares of OmniAb by 12.5% during the 3rd quarter. Palumbo Wealth Management LLC now owns 24,640 shares of the company’s stock worth $104,000 after acquiring an additional 2,744 shares in the last quarter. 72.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

OABI has been the subject of a number of research analyst reports. Benchmark reaffirmed a “buy” rating and issued a $8.00 price target on shares of OmniAb in a report on Thursday, November 14th. HC Wainwright restated a “buy” rating and issued a $11.00 target price on shares of OmniAb in a report on Thursday, November 14th.

OmniAb Stock Down 0.6 %

Shares of NASDAQ OABI opened at $3.54 on Thursday. The business has a 50-day moving average price of $3.92 and a 200 day moving average price of $4.12. The stock has a market cap of $499.90 million, a PE ratio of -5.71 and a beta of -0.14. OmniAb, Inc. has a 52-week low of $3.43 and a 52-week high of $6.72.

About OmniAb

OmniAb, Inc, a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts.